• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类沉默调节蛋白2抑制剂、其作用机制及结合模式。

Human sirtuin 2 inhibitors, their mechanisms and binding modes.

作者信息

Penteado André Berndt, Hassanie Haifa, Gomes Renan Augusto, Silva Emery Flávio da, Goulart Trossini Gustavo Henrique

机构信息

School of Pharmaceutical Sciences, University of São Paulo, Av. Lineu Prestes, 580, Cidade Universitária, São Paulo, SP, 05508-000, Brazil.

School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Av. Café, s/n, Ribeirão Preto, SP, 14040-903, Brazil.

出版信息

Future Med Chem. 2023 Feb;15(3):291-311. doi: 10.4155/fmc-2022-0253. Epub 2023 Mar 9.

DOI:10.4155/fmc-2022-0253
PMID:36892013
Abstract

The silent information regulator (sirtuin) is a family of enzymes involved in epigenetic processes with lysine deacetylase activity, having as substrates histones and other proteins. They participate in a wide range of cellular and pathologic processes, such as gene expression, cell division and motility, oxidative-induced stress management, metabolic control and carcinogenesis, among others, thus presenting as interesting therapeutic targets. In this article, the authors describe the inhibitory mechanisms and binding modes of the human sirtuin 2 (hSIRT2) inhibitors, which had their complexes with the enzyme structurally characterized. The results help pave the way for the rational designing of new hSIRT2 inhibitors and the development of novel therapeutic agents targeting this epigenetic enzyme.

摘要

沉默信息调节因子(sirtuin)是一类参与表观遗传过程的酶家族,具有赖氨酸脱乙酰酶活性,其底物包括组蛋白和其他蛋白质。它们参与广泛的细胞和病理过程,如基因表达、细胞分裂与运动、氧化应激管理、代谢控制和致癌作用等,因此成为有趣的治疗靶点。在本文中,作者描述了人类沉默信息调节因子2(hSIRT2)抑制剂的抑制机制和结合模式,这些抑制剂与该酶的复合物已通过结构表征。这些结果有助于为合理设计新型hSIRT2抑制剂以及开发针对这种表观遗传酶的新型治疗药物铺平道路。

相似文献

1
Human sirtuin 2 inhibitors, their mechanisms and binding modes.人类沉默调节蛋白2抑制剂、其作用机制及结合模式。
Future Med Chem. 2023 Feb;15(3):291-311. doi: 10.4155/fmc-2022-0253. Epub 2023 Mar 9.
2
The Fungal Metabolite Eurochevalierine, a Sequiterpene Alkaloid, Displays Anti-Cancer Properties through Selective Sirtuin 1/2 Inhibition.真菌代谢产物欧洲水龙骨碱,一种倍半萜生物碱,通过选择性抑制 Sirtuin 1/2 发挥抗癌特性。
Molecules. 2018 Feb 5;23(2):333. doi: 10.3390/molecules23020333.
3
Biophysical insights into the dimer formation of human Sirtuin 2.人源 Sirtuin 2 二聚体形成的生物物理研究进展
Protein Sci. 2024 May;33(5):e4994. doi: 10.1002/pro.4994.
4
Deacetylase enzymes: biological functions and the use of small-molecule inhibitors.脱乙酰酶:生物学功能及小分子抑制剂的应用
Chem Biol. 2002 Jan;9(1):3-16. doi: 10.1016/s1074-5521(02)00092-3.
5
High glucose-induced oxidative stress represses sirtuin deacetylase expression and increases histone acetylation leading to neural tube defects.高糖诱导的氧化应激会抑制沉默调节蛋白去乙酰化酶的表达,并增加组蛋白乙酰化,从而导致神经管缺陷。
J Neurochem. 2016 May;137(3):371-83. doi: 10.1111/jnc.13587. Epub 2016 Mar 17.
6
Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening.通过表型筛选鉴定一类烟酰胺腺嘌呤二核苷酸(NAD)依赖性去乙酰化酶的沉默调节蛋白家族的小分子抑制剂。
J Biol Chem. 2001 Oct 19;276(42):38837-43. doi: 10.1074/jbc.M106779200. Epub 2001 Aug 1.
7
Chemical and structural biology of protein lysine deacetylases.蛋白质赖氨酸脱乙酰酶的化学与结构生物学
Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(5):297-321. doi: 10.2183/pjab.93.019.
8
dSIR2 and dHDAC6: two novel, inhibitor-resistant deacetylases in Drosophila melanogaster.dSIR2和dHDAC6:果蝇中两种新型的、抗抑制剂的脱乙酰酶。
Exp Cell Res. 2001 Apr 15;265(1):90-103. doi: 10.1006/excr.2001.5162.
9
Histone H4 lysine 16 acetylation regulates cellular lifespan.组蛋白H4赖氨酸16乙酰化调节细胞寿命。
Nature. 2009 Jun 11;459(7248):802-7. doi: 10.1038/nature08085.
10
Erasers of histone acetylation: the histone deacetylase enzymes.组蛋白乙酰化的橡皮擦:组蛋白去乙酰化酶。
Cold Spring Harb Perspect Biol. 2014 Apr 1;6(4):a018713. doi: 10.1101/cshperspect.a018713.

引用本文的文献

1
Structural basis for sirtuin 2 activity and modulation: Current state and opportunities.沉默调节蛋白2的活性与调控的结构基础:现状与机遇
J Biol Chem. 2025 May 22;301(7):110274. doi: 10.1016/j.jbc.2025.110274.
2
SIRT2 inhibition enhances mitochondrial apoptosis in Brucella-infected bovine placental trophoblast cells.SIRT2抑制增强布鲁氏菌感染的牛胎盘滋养层细胞中的线粒体凋亡。
Vet Res. 2025 May 2;56(1):97. doi: 10.1186/s13567-025-01518-8.
3
Suppression of Hepatocellular Carcinoma by Deletion of SIRT2 in Hepatocytes via Elevated C/EBPβ/GADD45γ.
通过升高C/EBPβ/GADD45γ,肝细胞中SIRT2缺失抑制肝细胞癌
Cell Mol Gastroenterol Hepatol. 2025;19(7):101494. doi: 10.1016/j.jcmgh.2025.101494. Epub 2025 Mar 11.
4
Symmetrical 2,7-disubstituted 9H-fluoren-9-one as a novel and promising scaffold for selective targeting of SIRT2.对称的2,7-二取代9H-芴-9-酮作为一种新型且有前景的选择性靶向SIRT2的骨架。
Arch Pharm (Weinheim). 2024 Dec;357(12):e2400661. doi: 10.1002/ardp.202400661. Epub 2024 Sep 28.
5
Protein lipidation in cancer: mechanisms, dysregulation and emerging drug targets.癌症中的蛋白质脂质化:机制、失调和新出现的药物靶点。
Nat Rev Cancer. 2024 Apr;24(4):240-260. doi: 10.1038/s41568-024-00666-x. Epub 2024 Feb 29.
6
The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk.衰老和氧化应激对代谢和神经系统疾病的影响:程序性细胞死亡和分子信号转导的串扰。
Front Immunol. 2023 Nov 8;14:1273570. doi: 10.3389/fimmu.2023.1273570. eCollection 2023.
7
5-((3-Amidobenzyl)oxy)nicotinamides as SIRT2 Inhibitors: A Study of Constrained Analogs.5-((3-氨甲基)苄氧基)烟酰胺类作为 SIRT2 抑制剂:约束类似物的研究。
Molecules. 2023 Nov 18;28(22):7655. doi: 10.3390/molecules28227655.
8
Pyruvate kinase is post-translationally regulated by sirtuin 2 in Aedes aegypti mosquitoes.丙酮酸激酶在埃及伊蚊中受 Sirtuin 2 的翻译后调控。
Insect Biochem Mol Biol. 2023 Nov;162:104015. doi: 10.1016/j.ibmb.2023.104015. Epub 2023 Oct 4.
9
The Metabolic Basis for Nervous System Dysfunction in Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.阿尔茨海默病、帕金森病和亨廷顿病的神经系统功能障碍的代谢基础。
Curr Neurovasc Res. 2023;20(3):314-333. doi: 10.2174/1567202620666230721122957.